Gut health business Microba Life Sciences Ltd (ASX:MAP) listed on the Australian Securities Exchange in an IPO that raised A$30 million with assistance from Thomson Geer. Microba provides microbiome testing services and is developing therapies to treat chronic diseases such as inflammatory bowel disease. The company operates in the emerging US$4.89 billion gut microbiome sector.

The Thomson Geer team included Emma Cook, Senior Associate Belinda Pinnow and Lawyer Robin Mahly.